Identification of a Predictive Pre-Chemotherapy Score for Febrile Neutropenia - the Fnipi INDEX

被引：0
|
作者：
Sanna, Marco
Caocci, Giovanni
Ledda, Antonio
Belardinelli, Elisabetta
Garau, Pietro
Fanni, Alessandro
Romani, Claudio
La Nasa, Giorgio
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
    Aapro, M.
    Ludwig, H.
    Bokemeyer, C.
    Gascon, P.
    Boccadoro, M.
    Denhaerynck, K.
    Krendyukov, A.
    Gorray, M.
    MacDonald, K.
    Abraham, I.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2039 - 2045
  • [32] Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study
    Beleva, Elina
    Stoencheva, Snezhana
    Deneva, Tanya
    Nenova, Ivanka
    Grudeva-Popova, Zhanet
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (02): : 287 - 297
  • [33] c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia
    Kubo, Hiroyuki
    Imataki, Osamu
    Kubo, Yukiko Hamasaki
    Uemura, Makiko
    PLOS ONE, 2022, 17 (03):
  • [34] A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma
    Intragumtornchai, T
    Sutheesophon, J
    Sutcharitchan, P
    Swasdikul, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 351 - 360
  • [35] c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
    Kubo, Hiroyuki
    Imataki, Osamu
    Kubo, Yukiko Hamasaki
    Uemura, Makiko
    Kadowaki, Norimitsu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 590 - 595
  • [36] c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
    Hiroyuki Kubo
    Osamu Imataki
    Yukiko Hamasaki Kubo
    Makiko Uemura
    Norimitsu Kadowaki
    International Journal of Clinical Oncology, 2019, 24 : 590 - 595
  • [37] Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer
    Lote, H.
    Sharp, A.
    Redana, S.
    Papadimitraki, E.
    Capelan, M.
    Ring, A.
    CLINICAL ONCOLOGY, 2016, 28 (09) : 597 - 603
  • [38] Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSRFENCE score
    Aagaard, Theis
    Reekie, Joanne
    Roen, Ashley
    Daugaard, Gedske
    Specht, Lena
    Sengelov, Henrik
    Mocroft, Amanda
    Lundgren, Jens
    Helleberg, Marie
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 321 - 328
  • [39] A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of chop chemotherapy in patients with aggressive non-Hodgkin's lymphoma.
    Intragumtornchai, T
    Sutheesophon, J
    Sutcharitjan, P
    Swasdikul, D
    BLOOD, 1998, 92 (10) : 225B - 225B
  • [40] Procalcitonin (PCT) as an adjunct to the Multinational Association of Supportive Care in Cancer (MASCC) risk-index score in cancer patients with febrile neutropenia
    Uys, A
    Fickl, H
    Meyer, PWA
    Anderson, R
    Rapoport, BL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 759S - 759S
12345